Cite
Short-chain fatty acid-butyric acid ameliorates granulosa cells inflammation through regulating METTL3-mediated N6-methyladenosine modification of FOSL2 in polycystic ovarian syndrome.
MLA
Liu, Kailu, et al. “Short-Chain Fatty Acid-Butyric Acid Ameliorates Granulosa Cells Inflammation through Regulating METTL3-Mediated N6-Methyladenosine Modification of FOSL2 in Polycystic Ovarian Syndrome.” Clinical Epigenetics, vol. 15, no. 1, May 2023, pp. 1–18. EBSCOhost, https://doi.org/10.1186/s13148-023-01487-9.
APA
Liu, K., He, X., Huang, J., Yu, S., Cui, M., Gao, M., Liu, L., Qian, Y., Xie, Y., Hui, M., Hong, Y., & Nie, X. (2023). Short-chain fatty acid-butyric acid ameliorates granulosa cells inflammation through regulating METTL3-mediated N6-methyladenosine modification of FOSL2 in polycystic ovarian syndrome. Clinical Epigenetics, 15(1), 1–18. https://doi.org/10.1186/s13148-023-01487-9
Chicago
Liu, Kailu, Xi He, Jingyu Huang, Simin Yu, Meiting Cui, Mengya Gao, Li Liu, et al. 2023. “Short-Chain Fatty Acid-Butyric Acid Ameliorates Granulosa Cells Inflammation through Regulating METTL3-Mediated N6-Methyladenosine Modification of FOSL2 in Polycystic Ovarian Syndrome.” Clinical Epigenetics 15 (1): 1–18. doi:10.1186/s13148-023-01487-9.